血液透析期间高蛋白餐联合碳酸镧对低白蛋白血症透析患者的影响:FrEDI随机对照试验结果
FrEDI随机对照试验在110例血清白蛋白低于4.0 g/dL的血液透析患者中比较透析期间高蛋白餐(50-55 g,含磷400-500 mg)联合碳酸镧与低蛋白餐(<1 g,含磷<20 mg)的效果。符合入组标准的106例中,高蛋白组27%(15例)vs 低蛋白组12%(6例)达到主要复合终点(意向性治疗P=0.045)。高蛋白组白细胞介素-6有意义升高的比例较低蛋白组更低(9% vs 31%,P=0.009),未观察到严重不良事件。
要点
- 透析期间高蛋白餐联合碳酸镧组27%达到主要复合终点,低蛋白餐组为12%(P=0.045)。
- 高蛋白组白细胞介素-6有意义升高的比例为9%,低蛋白组为31%(P=0.009)。
- 研究未观察到严重不良事件,高蛋白餐联合碳酸镧被认为安全。
核心结论
- 在低白蛋白血症血液透析患者中,透析期间高蛋白餐联合碳酸镧安全,可在控制血磷的同时升高血清白蛋白。
研究设计与样本
- 随机对照试验,2010年7月至2011年10月从南加州8个透析中心招募110例接受每周三次血液透析、血清白蛋白<4.0 g/dL的成人患者。
主要发现
- 符合试验入组条件的106例中,高蛋白透析餐组27%(n=15)与低蛋白透析餐组12%(n=6)达到主要复合终点(意向性治疗P=0.045)。
- 高蛋白摄入组较低蛋白摄入组发生白细胞介素-6有意义升高的比例更低:9% vs 31%(P=0.009)。
- 未观察到严重不良事件。
临床怎么用
- 原文未据此给出推荐。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Inadequate protein intake and hypoalbuminemia, indicators of protein-energy wasting, are among the strongest mortality predictors in hemodialysis patients. Hemodialysis patients are frequently counseled on dietary phosphorus restriction, which may inadvertently lead to decreased protein intake. We hypothesized that, in hypoalbuminemic hemodialysis patients, provision of high-protein meals during hemodialysis combined with a potent phosphorus binder increases serum albumin without raising phosphorus levels. METHODS: We conducted a randomized controlled trial in 110 adults undergoing thrice-weekly hemodialysis with serum albumin <4.0 g/dL recruited between July 2010 and October 2011 from eight Southern California dialysis units. Patients were randomly assigned to receive high-protein (50-55 g) meals during dialysis, providing 400-500 mg phosphorus, combined with lanthanum carbonate versus low-protein (<1 g) meals during dialysis, providing <20 mg phosphorus. Prescribed nonlanthanum phosphorus binders were continued over an 8-week period. The primary composite outcome was a rise in serum albumin of ≥0.2 g/dL while maintaining phosphorus between 3.5-<5.5 mg/dL. Secondary outcomes included achievement of the primary outcome's individual endpoints and changes in mineral and bone disease and inflammatory markers. RESULTS: Among 106 participants who satisfied the trial entrance criteria, 27% ( n = 15) and 12% ( n = 6) of patients in the high-protein versus low-protein hemodialysis meal groups, respectively, achieved the primary outcome (intention-to-treat P-value = 0.045). A lower proportion of patients in the high-protein versus low-protein intake groups experienced a meaningful rise in interleukin-6 levels: 9% versus 31%, respectively (P = 0.009). No serious adverse events were observed. CONCLUSION: In hypoalbuminemic hemodialysis patients, high-protein meals during dialysis combined with lanthanum carbonate are safe and increase serum albumin while controlling phosphorus.
引用
- Rhee CM, You AS, Koontz Parsons T, et al. Effect of high-protein meals during hemodialysis combined with lanthanum carbonate in hypoalbuminemic dialysis patients: findings from the FrEDI randomized controlled trial. Nephrol Dial Transplant. 2017. PMID: 27659126. doi:10.1093/ndt/gfw323
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。